OMADA HEALTH INC (OMDA) Stock Fundamental Analysis

NASDAQ:OMDA • US68170A1088

11.31 USD
+0.08 (+0.71%)
At close: Feb 13, 2026
11.3 USD
-0.01 (-0.09%)
After Hours: 2/13/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to OMDA. OMDA was compared to 102 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for OMDA as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, OMDA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • OMDA had negative earnings in the past year.
OMDA Yearly Net Income VS EBIT VS OCF VS FCFOMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • OMDA has a Return On Assets of -22.64%. This is amonst the worse of the industry: OMDA underperforms 80.39% of its industry peers.
  • With a Return On Equity value of -29.94%, OMDA is not doing good in the industry: 67.65% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -22.64%
ROE -29.94%
ROIC N/A
ROA(3y)-34.16%
ROA(5y)N/A
ROE(3y)-62.59%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OMDA Yearly ROA, ROE, ROICOMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60

1.3 Margins

  • OMDA's Gross Margin of 62.16% is amongst the best of the industry. OMDA outperforms 83.33% of its industry peers.
  • OMDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OMDA Yearly Profit, Operating, Gross MarginsOMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • OMDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OMDA remains at a similar level compared to 1 year ago.
  • The debt/assets ratio for OMDA is higher compared to a year ago.
OMDA Yearly Shares OutstandingOMDA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
OMDA Yearly Total Debt VS Total AssetsOMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 4.64 indicates that OMDA is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of OMDA (4.64) is better than 80.39% of its industry peers.
  • OMDA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.64
ROIC/WACCN/A
WACC8.86%
OMDA Yearly LT Debt VS Equity VS FCFOMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • OMDA has a Current Ratio of 3.64. This indicates that OMDA is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.64, OMDA belongs to the best of the industry, outperforming 87.25% of the companies in the same industry.
  • OMDA has a Quick Ratio of 3.59. This indicates that OMDA is financially healthy and has no problem in meeting its short term obligations.
  • OMDA has a better Quick ratio (3.59) than 88.24% of its industry peers.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.59
OMDA Yearly Current Assets VS Current LiabilitesOMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.18% over the past year.
  • OMDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.29%.
EPS 1Y (TTM)30.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)38.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 31.07% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, OMDA will show a very strong growth in Revenue. The Revenue will grow by 30.85% on average per year.
EPS Next Y69.17%
EPS Next 2Y38.65%
EPS Next 3Y31.07%
EPS Next 5YN/A
Revenue Next Year52.49%
Revenue Next 2Y36.77%
Revenue Next 3Y30.85%
Revenue Next 5YN/A

3.3 Evolution

OMDA Yearly Revenue VS EstimatesOMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OMDA Yearly EPS VS EstimatesOMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OMDA. In the last year negative earnings were reported.
  • Also next year OMDA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OMDA Price Earnings VS Forward Price EarningsOMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OMDA Per share dataOMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as OMDA's earnings are expected to grow with 31.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.65%
EPS Next 3Y31.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for OMDA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OMADA HEALTH INC

NASDAQ:OMDA (2/13/2026, 8:00:01 PM)

After market: 11.3 -0.01 (-0.09%)

11.31

+0.08 (+0.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)03-05
Inst Owners71.7%
Inst Owner Change-1.14%
Ins Owners6.23%
Ins Owner Change27.73%
Market Cap654.96M
Revenue(TTM)354.16M
Net Income(TTM)-65.07M
Analysts78.82
Price Target27.08 (139.43%)
Short Float %3.12%
Short Ratio1.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.37%
Min EPS beat(2)5.88%
Max EPS beat(2)22.85%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.17%
Min Revenue beat(2)9.04%
Max Revenue beat(2)9.3%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.15%
PT rev (3m)-6.31%
EPS NQ rev (1m)0.35%
EPS NQ rev (3m)20.46%
EPS NY rev (1m)-0.5%
EPS NY rev (3m)39.32%
Revenue NQ rev (1m)0.93%
Revenue NQ rev (3m)10.49%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)6.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.85
P/FCF N/A
P/OCF N/A
P/B 3.01
P/tB 3.25
EV/EBITDA N/A
EPS(TTM)-1.17
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.12
BVpS3.75
TBVpS3.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22.64%
ROE -29.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.16%
FCFM N/A
ROA(3y)-34.16%
ROA(5y)N/A
ROE(3y)-62.59%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.64
Quick Ratio 3.59
Altman-Z 4.64
F-ScoreN/A
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)69.64%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y69.17%
EPS Next 2Y38.65%
EPS Next 3Y31.07%
EPS Next 5YN/A
Revenue 1Y (TTM)38.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year52.49%
Revenue Next 2Y36.77%
Revenue Next 3Y30.85%
Revenue Next 5YN/A
EBIT growth 1Y33.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.04%
EBIT Next 3Y33.24%
EBIT Next 5YN/A
FCF growth 1Y27.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.28%
OCF growth 3YN/A
OCF growth 5YN/A

OMADA HEALTH INC / OMDA FAQ

Can you provide the ChartMill fundamental rating for OMADA HEALTH INC?

ChartMill assigns a fundamental rating of 4 / 10 to OMDA.


Can you provide the valuation status for OMADA HEALTH INC?

ChartMill assigns a valuation rating of 1 / 10 to OMADA HEALTH INC (OMDA). This can be considered as Overvalued.


Can you provide the profitability details for OMADA HEALTH INC?

OMADA HEALTH INC (OMDA) has a profitability rating of 1 / 10.


What is the expected EPS growth for OMADA HEALTH INC (OMDA) stock?

The Earnings per Share (EPS) of OMADA HEALTH INC (OMDA) is expected to grow by 69.17% in the next year.